Hashem A. Dbouk

Science/medical writer, major disease states: oncology, COPD, inflammatory disorders. Kinase afficionado. YNWA. All opinions are my own.

[Hashem A. Dbouk @hashemdbouk]

After 5 years since I initiated this project, my article "WNK1 Kinase Controls Podocyte Cytoskeletal and Glomerular Capillary Wall Structure and Elasticity" is finally accepted #WNK #kinase #cellbiology #cellsignaling #kidney #glomerulus #science https://t.co/sThXCfs1O4

[⚽️ OLSC Richmond ⚽️ @OLSCRichmond]

Attention Virginia Liverpool Fans: If you would like to show your love of LFC on your car, you can now pre-register for an Official Liverpool Supporters Club License plate in Virginia.

Sign up today at https://t.co/gmd653Qi3P

$10 for standard, $20 personalized (plus fees)

[Hashem A. Dbouk @hashemdbouk]

Baby’s first time seeing Steven Gerard #MYPLmorning

[David Brown @daveb0211]

Is this the worst ever presentation of live sport? #EURO2020 #ESPN+

[Hashem A. Dbouk @hashemdbouk]

Novartis gene therapy Zolgensma cleared for use in Europe https://t.co/affd77qosS @BioPharmaDive #spinalmuscularatrophy #pharma #genetherapy #raredisease #novartis

[Hashem A. Dbouk @hashemdbouk]

Happy birthday to the one and only @DivockOrigi #YNWA

[Liverpool FC @LFC]

𝙎𝙖𝙩𝙪𝙧𝙙𝙖𝙮 𝙣𝙞𝙜𝙝𝙩 𝙖𝙣𝙙 𝙄 𝙡𝙞𝙠𝙚 𝙩𝙝𝙚 𝙬𝙖𝙮 𝙮𝙤𝙪 𝙢𝙤𝙫𝙚, 𝘿𝙄𝙑𝙊𝘾𝙆 𝙊𝙍𝙄𝙂𝙄! 🤩🔥

[Liverpool FC USA @LFCUSA]

That James Milner magic 😍

[Hashem A. Dbouk @hashemdbouk]

In a CRISPR first, Editas therapy used to fix genes in the body #CRISPR #pharma https://t.co/sBPxo0Pu8M via @BioPharmaDive

[Hashem A. Dbouk @hashemdbouk]

Bobbi!! #YNWA #bobbifirmino #LiverpoolFC

[Liverpool FC @LFC]

After receiving his milestone award...

Enjoy Bobby's first 5⃣0⃣ @premierleague goals for the Reds 😍

[Hashem A. Dbouk @hashemdbouk]

Really Rapid Review of IAS 2019 Mexico City #HIV #HIVtherapy #IAS2019 https://t.co/IcD7RHgGMq

[Nature Reviews Drug Discovery @NatRevDrugDisc]

This new Review discusses the different therapeutic approaches to develop oncolytic viruses for patients with cancer, including delivery modalities and methods for assessing their biological activity. Read more here https://t.co/eZSWaIKaz3 @jsoriamd

[Hashem A. Dbouk @hashemdbouk]

At ASCO, debate over speedy drug approvals in the spotlight #cancertherapy #fda #ASCO #pharma https://t.co/GsDeIaVKA1 via @BioPharmaDive

[Hashem A. Dbouk @hashemdbouk]

5 novel immuno-oncology targets to know before ASCO #cancer #ASCO #immunooncology https://t.co/pYRTzZaLhv via @BioPharmaDive

[Hashem A. Dbouk @hashemdbouk]

Clinical trials for protein "degrader" therapeutics #pharma #therapeutics #protein #cellbiology https://t.co/TT9iLlHSOK

[Hashem A. Dbouk @hashemdbouk]

AstraZeneca inks ambitious $6.9B deal for Daiichi cancer therapy #cancertherapy #pharma #astrazeneca https://t.co/XeAhY5PpL8 via @BioPharmaDive

[Hashem A. Dbouk @hashemdbouk]

After US FDA acceptance of BLA filing, Aimmune's peanut drug moves closer to European market #pharma #Aimmunetherapeutics #peanutallergy https://t.co/bBjSFSYO1h via @BioPharmaDive

[Hashem A. Dbouk @hashemdbouk]

Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech #pharmanews #pharma #alzheimer #backtothedrawingboard https://t.co/NpRophwim1 via @BioPharmaDive

[Hashem A. Dbouk @hashemdbouk]

BIG pharma news: Bristol-Myers Squibb to buy Celgene for around $74 billion #pharma #BMS #Celgene https://t.co/BBfqKC4fc2 via @fwpharma

[Hashem A. Dbouk @hashemdbouk]

Gilead, Agenus to partner on development of immuno-oncology therapies in deal potentially worth over $1.8 billion. #pharma #pharmanews #immunooncology #cancertherapy https://t.co/RiKm2dJ5Q7 via @fwpharma

[Hashem A. Dbouk @hashemdbouk]

China becomes first country to approve AstraZeneca, FibroGen's anaemia drug roxadustat #anemia #CKD #china #pharma https://t.co/kSSZsPALpk via @fwpharma